NCT05984615
- Conditions
- BRAF Positive Metastatic Melanoma
- Locations
-
- Novartis East Hanover, New Jersey, United States
Clinical trial condition
BRAF Positive Metastatic Melanoma
Explore clinical trials studying BRAF Positive Metastatic Melanoma. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies